CHARLES RIVER LABORATORIES (CRL)
US1598641074 - Common Stock
Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
Friday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Top S&P500 movers in Thursday's session
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Thursday Sector Laggards: Industrial, Healthcare
Wednesday's session: top gainers and losers in the S&P500 index
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.
Wednesday Sector Laggards: Utilities, Healthcare
Top S&P500 movers in Wednesday's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.
These S&P500 stocks are gapping in today's session
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends.
Charles River Laboratories to Present at UBS and Jefferies Conferences
What's going on in today's session: S&P500 movers
These S&P500 stocks are moving in today's session
Wednesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
Charles River Laboratories Announces Third-Quarter 2024 Results
December 20th Options Now Available For Charles River Laboratories International (CRL)
Charles River Launches New Retrogenix® Non-Human Protein Library
Charles River Laboratories International Moves Up In Market Cap Rank, Passing Hasbro
Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
Comparing Bitcoin Versus Charles River Reveals New Low
Charles River Provides Translational Expertise at Neuroscience 2024
Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease
Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
/PRNewswire/ -- Charles River Laboratories International, Inc. (NYSE: CRL) and Insightec, a global healthcare company dedicated to using focused ultrasound to...
Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
Wednesday Sector Laggards: Healthcare, Materials
Agree To Purchase Charles River Laboratories International At $155, Earn 5.8% Using Options
CRL Crosses Below Key Moving Average Level
Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024
Pharmaceutical demand hit the skids in the second quarter and isn't expected to improve this year.
Charles River Laboratories Announces Second-Quarter 2024 Results
Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
